Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Recombinant Human Growth Hormone: Molecular Mechanisms, Assa
2026-05-05
Explore the molecular underpinnings and assay optimization strategies for Recombinant Human Growth Hormone (GH, somatotropin), including new evidence on the IGFBP2-THBS1 axis. This in-depth analysis advances pituitary growth hormone research and supports next-generation cell proliferation studies.
-
Palbociclib (PD0332991) Isethionate: Next-Gen Tumor Modeling
2026-05-04
Explore how Palbociclib (PD0332991) Isethionate revolutionizes complex tumor modeling and personalized drug screening. This article reveals unique, advanced applications in assembloid systems, deepening practical assay design for cancer research.
-
Artesunate in Cancer Systems Biology: Mechanistic and Quanti
2026-05-04
Explore Artesunate, a leading artemisinin derivative, through the lens of quantitative systems biology and assay optimization for cancer research. This article delivers unique guidance for integrating Artesunate in advanced in vitro studies, grounded in recent scientific innovations.
-
Patient-Derived Gastric Cancer Assembloids Advance Tumor Mic
2026-05-03
The referenced study presents a patient-derived gastric cancer assembloid platform that integrates matched tumor organoids with autologous stromal cell subpopulations, closely recapitulating the native tumor niche. This innovation enables nuanced investigation of tumor–stroma interactions, drug resistance, and personalized therapy development.
-
CFDA SE Cell Tracer Kit: Practical Guide for Long-Term Cell
2026-05-02
The CFDA SE (carboxyfluorescein diacetate succinimidyl ester) Cell Tracer Kit addresses the need for robust, long-term fluorescent labeling in cell proliferation studies and cell lineage tracing. It is designed for workflows where stable, covalent, and minimally cytotoxic labeling is required, but is not suitable for reversible or short-term labeling needs.
-
Amorolfine Hydrochloride in Polyploidy-Driven Fungal Researc
2026-05-02
Explore how Amorolfine Hydrochloride empowers advanced antifungal research by targeting cell membrane biosynthesis in polyploid fungi. This article offers unique assay guidance, protocol parameters, and evidence-based insights for research on fungal cell integrity and adaptive stress.
-
40-Hz Light Flicker Enhances Retinal Amyloid Clearance via M
2026-05-01
This study reveals that 40-Hz light flicker stimulates retinal microglia to clear amyloid-β (Aβ) by upregulating MHC-II expression in aged mice. The findings highlight a non-invasive approach for metabolic waste removal in the retina and demonstrate the utility of microglial modulation in age-related retinal disease models.
-
Cell Tumbling Regulates Stem Cell Fate via Nuclear Mechanotr
2026-04-30
A recent study uncovers 'cell tumbling'—a rapid, 3D whole-cell movement in hydrogels—as a novel regulator of stem cell differentiation through nuclear mechanotransduction. These findings expand understanding of how short-timescale mechanics in engineered microenvironments direct cell fate and have implications for designing advanced tissue engineering platforms.
-
Bestatin (Ubenimex): Precision Aminopeptidase Inhibition Red
2026-04-30
This thought-leadership article explores the mechanistic underpinnings and translational strategy of Bestatin (Ubenimex) as a selective aminopeptidase inhibitor. Integrating cutting-edge evidence from chemical genetics and multidrug resistance research, it offers actionable guidance for experimental design, protocol optimization, and future innovation in cancer and plant signaling studies. The content distinguishes itself by bridging validated molecular mechanism with strategic insights and by contextualizing APExBIO’s Bestatin within the broader experimental and clinical landscape.
-
Transmission of Carbapenemase Genes in CREC: Insights from G
2026-04-29
This study provides a detailed molecular characterization of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) across eight teaching hospitals in Guangdong, China. By mapping the prevalence, mobility, and clinical associations of these resistance determinants, the work advances the understanding of antimicrobial resistance dynamics during the COVID-19 era.
-
Cinoxacin: Mechanisms, Spectrum, and Pharmacokinetics in UTI
2026-04-29
This article reviews the landmark study detailing Cinoxacin’s mechanism as a quinolone antibiotic, its potent bactericidal spectrum against Gram-negative uropathogens, and its pharmacokinetic features relevant to urinary tract infection research. Key evidence on resistance, clinical efficacy, and adverse events informs both experimental and translational protocols.
-
Temafloxacin’s In Vitro Potency Against Gram-Negative Bacter
2026-04-28
This article reviews the pivotal findings of Hardy et al. on temafloxacin’s in vitro activity against gram-negative bacteria, highlighting its spectrum, comparative potency, and relevance for antibiotic resistance studies. The study’s quantitative MIC data provide a critical benchmark for researchers developing or benchmarking quinolone antibiotics against established antibacterial agents.
-
Applied Workflows with Minocycline HCl in EV and Inflammatio
2026-04-28
Minocycline HCl, a semisynthetic tetracycline antibiotic, is redefining experimental design for neuroprotection and scalable extracellular vesicle (EV) studies. Discover protocol-ready strategies, troubleshooting insights, and data-driven guidance to maximize reproducibility and translational relevance using APExBIO’s high-purity Minocycline HCl.
-
GSK343 and the Epigenetic Control of TERT: New Frontiers in
2026-04-27
Explore how GSK343, a potent EZH2 inhibitor, is redefining the study of histone H3K27 trimethylation and TERT gene regulation in cancer research. This article uniquely bridges chromatin silencing with telomerase expression, offering advanced insights for experimental design.
-
KPT-330 (Selinexor): Optimizing CRM1 Inhibition in Cancer Re
2026-04-27
KPT-330 (Selinexor) empowers researchers to dissect nuclear export mechanisms and drive apoptosis in resistant cancer models. This guide details protocol enhancements, troubleshooting strategies, and translational insights—grounded in the latest preclinical findings on combination therapies.